ENTEROMEDICS
EnteroMedics® Inc. is the developer of vBloc® neurometabolic therapy, delivered by a pacemaker-like device called the Maestro® Rechargeable System, a first-in-class weight loss treatment for obesity and obesity related risk factors, such as high blood pressure or high cholesterol levels. vBloc Therapy is a non-anatomy altering or restricting, reversible therapy that allows patients to safely lose weight by helping patients feel less hungry, reduce the amount of food eaten at a meal, and feel full longer in between meals.
ENTEROMEDICS
Industry:
Biotechnology Health Care Medical Device Therapeutics
Founded:
2002-01-01
Address:
Saint Paul, Minnesota, United States
Country:
United States
Website Url:
http://www.enteromedics.com
Total Employee:
11+
Status:
Active
Contact:
(800) 698-2562
Email Addresses:
[email protected]
Total Funding:
161.2 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Spero Therapeutics
Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2017-10-03 | ReShape Lifesciences | ReShape Lifesciences acquired by EnteroMedics | 61 M USD |
| 2017-05-23 | BarioSurg | BarioSurg acquired by EnteroMedics | N/A |
Investors List
Aberdare Ventures
Aberdare Ventures investment in Post-IPO Equity - EnteroMedics
MPM Capital
MPM Capital investment in Post-IPO Equity - EnteroMedics
Bay City Capital
Bay City Capital investment in Post-IPO Equity - EnteroMedics
Bay City Capital
Bay City Capital investment in Series A - EnteroMedics
Official Site Inspections
http://www.enteromedics.com Semrush global rank: 884.96 K Semrush visits lastest month: 42.03 K
- Host name: 104.21.23.131
- IP address: 104.21.23.131
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
